We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$6.01B
AUM Growth
+$30M
Cap. Flow
-$124M
Cap. Flow %
-2.06%
Top 10 Hldgs %
20.68%
Holding
237
New
8
Increased
68
Reduced
128
Closed
7

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$26.7M
2
CLF icon
Cleveland-Cliffs
CLF
+$8.36M
3
AA icon
Alcoa
AA
+$6.82M
4
HLN icon
Haleon
HLN
+$6.62M
5
IFF icon
International Flavors & Fragrances
IFF
+$5.76M

Sector Composition

Rank Sector Weight
1 Financials 18%
2 Technology 16.96%
3 Healthcare 15.96%
4 Industrials 9.91%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$423B
$78.9M 1.31%
848,855
-43,604
-5% -$3.82M
BAC icon
27
Bank of America
BAC
$442B
$78.3M 1.3%
2,736,516
-11,125
-0.4% -$367K
GSK icon
28
GSK
GSK
$106B
$76.9M 1.28%
2,162,290
+108,193
+5% +$3.79M
EQIX icon
29
Equinix
EQIX
$103B
$75.8M 1.26%
105,083
-2,552
-2% -$1.8M
KO icon
30
Coca-Cola
KO
$375B
$74.1M 1.23%
1,194,693
-16,953
-1% -$1.03M
CVX icon
31
Chevron
CVX
$366B
$73.2M 1.22%
448,864
-13,323
-3% -$2.23M
LOW icon
32
Lowe's Companies
LOW
$125B
$71.6M 1.19%
357,974
-28,427
-7% -$5.77M
IFF icon
33
International Flavors & Fragrances
IFF
$21.9B
$71M 1.18%
771,877
+57,897
+8% +$5.76M
ILMN icon
34
Illumina
ILMN
$28.4B
$70.5M 1.17%
311,715
-1,778
-0.6% -$364K
TDG icon
35
TransDigm Group
TDG
$67.7B
$68.5M 1.14%
92,946
-579
-0.6% -$414K
AES icon
36
AES
AES
$10.5B
$68.4M 1.14%
2,839,667
-43,163
-1% -$1.1M
STZ icon
37
Constellation Brands
STZ
$23.2B
$67.6M 1.12%
299,279
-14,854
-5% -$3.31M
SHEL icon
38
Shell
SHEL
$245B
$67.5M 1.12%
1,172,616
-38,141
-3% -$2.24M
IR icon
39
Ingersoll Rand
IR
$33.7B
$66.7M 1.11%
1,146,829
+14,911
+1% +$841K
AMT icon
40
American Tower
AMT
$80.4B
$64.5M 1.07%
315,875
-11
-0% -$2.31K
JNJ icon
41
Johnson & Johnson
JNJ
$625B
$64M 1.06%
412,671
+16,174
+4% +$2.61M
EOG icon
42
EOG Resources
EOG
$70.7B
$62.7M 1.04%
546,631
-25,216
-4% -$3.06M
DIS icon
43
Walt Disney
DIS
$181B
$59M 0.98%
589,050
+5,956
+1% +$600K
CVS icon
44
CVS Health
CVS
$122B
$58.7M 0.98%
789,655
+16,800
+2% +$1.41M
USB icon
45
US Bancorp
USB
$99.6B
$58.5M 0.97%
1,623,450
+11,188
+0.7% +$498K
HON icon
46
Honeywell
HON
$78B
$58.3M 0.97%
323,809
-4,621
-1% -$869K
MRK icon
47
Merck
MRK
$318B
$55.7M 0.93%
523,548
-14,584
-3% -$1.57M
HLN icon
48
Haleon
HLN
$44.2B
$54.2M 0.9%
6,663,769
+830,977
+14% +$6.62M
META icon
49
Meta Platforms (Facebook)
META
$1.51T
$52.2M 0.87%
246,433
-13,903
-5% -$2.37M
PYPL icon
50
PayPal
PYPL
$50.5B
$45.4M 0.75%
597,751
+23,352
+4% +$1.8M

Similar funds

Douglas Lane & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Douglas Lane & Associates held 237 positions worth $6.01B, up 0.5% from $5.98B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q1 2023 filing shows 8 new, 68 increased, 128 reduced and 7 closed positions. Its largest new stake was GE HealthCare: 374,583 shares worth $30.7M. The largest sale was NVIDIA, an estimated $31.7M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q1 2023 buy was GE HealthCare: 374,583 shares worth $30.7M.
  • Douglas Lane & Associates added most to Alcoa in Q1 2023, an estimated $6.82M increase.
  • Douglas Lane & Associates's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $31.7M.
  • Douglas Lane & Associates fully exited Safehold Inc. in Q1 2023, selling an estimated $1.13M.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $6.01B portfolio in Q1 2023.
  • Douglas Lane & Associates opened 8 new positions and closed 7 in Q1 2023.
  • Douglas Lane & Associates's portfolio value rose 0.5% quarter-over-quarter to $6.01B.

Based on Douglas Lane & Associates's 13F filing for Q1 2023, filed 17 Apr 2023.